Table 1

Treatment-specific cohort characteristics

No treatment (n = 137)IVIg (n = 47)Corticosteroids (n = 51)P value
All groupsIVIg vs corticosteroids
Maternal age (y), mean (SD) 32.7 (4.1) 31.1 (4.8) 30.5 (5.1) .01 .52 
Nulliparity (n), (%) 47 (34.3) 27 (57.5) 26 (51.0) .01 .52 
BMI (kg/m2), mean (SD) 27.9 (6.3) 27.9 (6.7) 28.5 (5.8) .92 .70 
Age at ITP diagnosis, mean (SD) 24.9 (7.2) 27.2 (6.5) 26.7 (6.0) .10 .72 
Maternal pretreatment platelet count (×109/L), mean (SD) NA 49 (25) 50 (22) — .80 
Neonatal platelet nadir (×109/L), mean (SD) 106 (76) 35 (21) 43 (26) <.0001 .11 
Gestational age at platelet nadir (wk), median (IQR) 36.0 (27.3-38.0) 36.0 (30.0-38.0) 34 (28.8-37.0) .31 .18 
Operative vaginal* delivery (n/N), (%) 9/106 (8.5) 1/35 (2.9) 1/43 (2.3) .38 .99 
Cesarean section, n (%) 53 (38.7) 20 (42.6) 15 (29.4) .36 .17 
No treatment (n = 137)IVIg (n = 47)Corticosteroids (n = 51)P value
All groupsIVIg vs corticosteroids
Maternal age (y), mean (SD) 32.7 (4.1) 31.1 (4.8) 30.5 (5.1) .01 .52 
Nulliparity (n), (%) 47 (34.3) 27 (57.5) 26 (51.0) .01 .52 
BMI (kg/m2), mean (SD) 27.9 (6.3) 27.9 (6.7) 28.5 (5.8) .92 .70 
Age at ITP diagnosis, mean (SD) 24.9 (7.2) 27.2 (6.5) 26.7 (6.0) .10 .72 
Maternal pretreatment platelet count (×109/L), mean (SD) NA 49 (25) 50 (22) — .80 
Neonatal platelet nadir (×109/L), mean (SD) 106 (76) 35 (21) 43 (26) <.0001 .11 
Gestational age at platelet nadir (wk), median (IQR) 36.0 (27.3-38.0) 36.0 (30.0-38.0) 34 (28.8-37.0) .31 .18 
Operative vaginal* delivery (n/N), (%) 9/106 (8.5) 1/35 (2.9) 1/43 (2.3) .38 .99 
Cesarean section, n (%) 53 (38.7) 20 (42.6) 15 (29.4) .36 .17 

BMI, body mass index; NA, not applicable.

*

Operative vaginal deliveries were carried out by vacuum extraction in all but 1 case in the nontreatment group, in which forceps were used.

or Create an Account

Close Modal
Close Modal